Alzheimer's Research UK is the United Kingdom's leading dementia research charity, founded in 1992 as the Alzheimer's Research Trust. In February 2011 Alzheimer's Research Trust renamed as the Alzheimer's Research UK. It is dedicated to funding scientific studies to find ways to treat, cure or prevent Alzheimer's disease, vascular dementia, Lewy Body disease and fronto-temporal dementia. Alzheimer's Research UK currently funds 127 research projects across the UK and has committed nearly £40million to dementia research. Alzheimer's Research UK is a member of the Association of Medical Research Charities. Alzheimer's Research UK does not receive any government funding and instead relies on donations from individuals, companies and charitable trusts, money raised by individuals and gifts left in people's Wills to fund dementia research. The charity was founded by four members of the public as a result of their deep concerns at the lack of funding for Alzheimer's research. In 1998, the Trust awarded its first first major grant of £500,000 to a team led by distinguished scientist Dr Michel Goedert in Cambridge.
Some content from Wikipedia, licensed under CC BY-SA
Subscribe to rss feed
Findings from a study led by researchers in Sweden have suggested that a commercial blood test could detect Alzheimer's disease as accurately as standard lumbar punctures. The blood test detects "p-tau217," a form of the ...
Jan 23, 2024
0
46
A new study suggests that sight loss in people over 71 years old may be linked to dementia. The study was published on July 13 in JAMA Ophthalmology.
Jul 14, 2023
0
72
Smokers are being urged to give quitting a go ahead of No Smoking Day (8th March), as research shows those who smoke are more likely to develop dementia.
Mar 6, 2023
0
25
Researchers have published findings which suggest that the use of hearing aids and cochlear implants can reduce the risk of developing dementia by slowing down cognitive decline, such as memory loss.
Dec 6, 2022
0
20
The pharmaceutical company Roche has announced that two phase III trials of the potential Alzheimer's drug gantenerumab did not achieve the goal of slowing clinical decline in participants with early Alzheimer's disease.
Nov 15, 2022
0
2
Research presented today (Monday 1 August) at the 2022 Alzheimer's Association International Conference (AAIC) in San Diego across two presentations suggest people who experience racism are more likely to have poor memory ...
Aug 2, 2022
0
2
Alzheimer's Research UK says Government must take greater action to speed up the development and deployment of new dementia treatments after it's been revealed that just over one in five (21.8%) individuals who died of COVID-19 ...
Jul 5, 2022
0
55
Research from the U.S. suggests that people who are organized and have self-discipline may be less likely to develop mild memory and thinking problems while those who are moodier may be at increased risk.
Apr 12, 2022
0
2
A series of experiments presented today at the Alzheimer's Research UK 2022 Conference at the Brighton Centre, has implicated the health of the gut in the development of Alzheimer's disease.
Mar 2, 2022
0
2
In December 2021 scientists from South Korea used a technology called transcranial ultrasound stimulation to excite specific areas of mice brain. They found mice with features of Alzheimer's had reduced levels of the hallmark ...
Jan 25, 2022
0
6
